Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue, 2020, Fitzgerald et al
Discussion in 'Other health news and research' started by Jaybee00, Aug 9, 2020.
Discussion in 'Other health news and research' started by Jaybee00, Aug 9, 2020.